NEONC TECHNOLOGIES HOLDINGS, INC. Amortization
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) reported Amortization of $6.94 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:AdjustmentForAmortization · last filed 2026-08-10
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization for the quarter ending 2026-06-30 was $6.94K.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization for the quarter ending 2026-03-31 was $11.57K.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization for the quarter ending 2025-12-31 was $312.17K, a 47.13% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization for the quarter ending 2025-09-30 was $438.11K, a 553.16% increase year-over-year.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization for fiscal 2025 was $1.11M, a 183.98% increase from fiscal 2024.
- NEONC TECHNOLOGIES HOLDINGS, INC. amortization for fiscal 2024 was $391.04K.
| Period end | Amortization 3 month | Amortization 6 month | Amortization 9 month | Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.94K 10-Q · filed 2026-08-10 | $18.52K 10-Q · filed 2026-08-10 | $330.69K derived: sum of 3 quarters · filed 2026-08-10 | $768.80K derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $11.57K 10-Q · filed 2026-05-15 | $323.75K derived: sum of 2 quarters · filed 2026-05-15 | $761.86K derived: sum of 3 quarters · filed 2026-05-15 | $761.86K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $312.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $750.28K derived: sum of 2 quarters · filed 2026-03-31 | $750.28K derived: sum of 3 quarters · filed 2026-08-10 | $1.11M 10-K · filed 2026-03-31 |
| 2025-09-30 | $438.11K 10-Q · filed 2025-11-14 | $438.11K derived: sum of 2 quarters · filed 2026-08-10 | $798.31K 10-Q · filed 2025-11-14 | $650.28K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 | $212.17K derived: sum of 3 quarters · filed 2026-08-10 | $279.25K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | $212.17K derived: sum of 2 quarters · filed 2026-05-15 | $279.25K derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $212.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $279.25K derived: sum of 2 quarters · filed 2026-03-31 | $391.04K 10-K · filed 2026-03-31 | |
| 2024-09-30 | $67.08K 10-Q · filed 2025-11-14 | $178.87K 10-Q · filed 2025-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |